The New Health Care: Why Preventing Cancer Is Not the Priority in Drug Development

http://www.nytimes.com/2015/12/29/upshot/why-preventing-cancer-is-not-the-priority-in-drug-development.html?partner=rss&emc=rss

The profits lie in treating later-stage cancers; a study shows it’s because of the incentives in the interplay between the patent system and the F.D.A. approval process.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s